Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1710-1492

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice ; volume:18 ; number:1 ; day:9 ; month:5 ; year:2022 ; pages:1-9 ; date:12.2022
Allergy, asthma and clinical immunology ; 18, Heft 1 (9.5.2022), 1-9, 12.2022

Creator: Portnoy, Jay
Ciaccio, Christina E.
Beausoleil, Janet
Toit, George Du
Fineman, Stanley
Tilles, Stephen A.
Zhang, June
Lawrence, Claire
Yassine, Mohamed
Mustafa, S Shahzad

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13223-022-00671-5

URN: urn:nbn:de:101:1-2022071607500333842512

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Portnoy, Jay
Ciaccio, Christina E.
Beausoleil, Janet
Toit, George Du
Fineman, Stanley
Tilles, Stephen A.
Zhang, June
Lawrence, Claire
Yassine, Mohamed
Mustafa, S Shahzad
SpringerLink (Online service)

Other Objects (12)

Peanut Allergy: An Overview

White paper peanut allergy : Part 3: management and therapy of peanut allergy

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy

Current developments in the treatment of peanut allergy

Adhesion molecules in experimental peanut allergy

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics

White paper on peanut allergy: treatment pathway

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Update on Allergy Immunotherapy

Peanut Allergy: An Overview

White paper peanut allergy : Part 3: management and therapy of peanut allergy

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy

Current developments in the treatment of peanut allergy

Adhesion molecules in experimental peanut allergy

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics

White paper on peanut allergy: treatment pathway

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Update on Allergy Immunotherapy

Peanut Allergy: An Overview

White paper peanut allergy : Part 3: management and therapy of peanut allergy

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy

Current developments in the treatment of peanut allergy

Adhesion molecules in experimental peanut allergy

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics

White paper on peanut allergy: treatment pathway

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Update on Allergy Immunotherapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Peanut Allergy: An Overview

White paper peanut allergy : Part 3: management and therapy of peanut allergy

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy

Current developments in the treatment of peanut allergy

Adhesion molecules in experimental peanut allergy

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics

White paper on peanut allergy: treatment pathway

White paper on peanut allergy: treatment pathway

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Update on Allergy Immunotherapy

Peanut Allergy: An Overview

White paper peanut allergy : Part 3: management and therapy of peanut allergy

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy

Current developments in the treatment of peanut allergy

Adhesion molecules in experimental peanut allergy

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics

White paper on peanut allergy: treatment pathway

White paper on peanut allergy: treatment pathway

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Update on Allergy Immunotherapy

Peanut Allergy: An Overview

White paper peanut allergy : Part 3: management and therapy of peanut allergy

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy

Current developments in the treatment of peanut allergy

Adhesion molecules in experimental peanut allergy

Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy

White paper peanut allergy—part 2: Diagnosis of peanut allergy with special emphasis on molecular component diagnostics

White paper on peanut allergy: treatment pathway

White paper on peanut allergy: treatment pathway

The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Update on Allergy Immunotherapy

Related objects

Reset password